Announcements Trials

Browse Landscape

Status

Unknown 1 Recruiting 1 Enrolling by invitation 1 Completed 1

Sponsor Class

OTHER 23 INDUSTRY 2 INDIV 2 NETWORK 1 FED 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 13 Leukemia, Myeloid, Acute 12 Colorectal Neoplasms 10 Carcinoma, Non-Small-Cell Lung 9 Rectal Neoplasms 8 Prostatic Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Neoplasms 6 Head and Neck Neoplasms 6 Fallopian Tube Neoplasms 6 Pancreatic Neoplasms 5 Multiple Myeloma 5 Leukemia 5 Uterine Cervical Neoplasms 4 Stomach Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Ovarian Neoplasms 4 Vulvar Neoplasms 3 Urinary Bladder Neoplasms 3 Recurrence 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Liver Neoplasms 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Fatigue 3 Depression 3 Central Nervous System Neoplasms 3 Carcinoma, Hepatocellular 3 Stress Disorders, Post-Traumatic 2 Small Cell Lung Carcinoma 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × NETWORK × Myasthenia Gravis × Clear all

NCT06259071 2024-02-14

MuSK 1000

Myasthenia Gravis Rare Disease Network

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡